{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:15:05Z","timestamp":1758672905006,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["endocrinologydiabetes.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Endocrinology and Diabetes"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.aed.2025.06.006","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:35:45Z","timestamp":1751430945000},"page":"190-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thyrotropin (TSH)-Binding Inhibiting Immunoglobulin-Negative, Thyroid-Stimulating Antibody-Positive Amiodarone-Induced Thyrotoxicosis"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1950-7704","authenticated-orcid":false,"given":"Yasufumi","family":"Seki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Inai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aed.2025.06.006_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1210\/clinem\/dgaa686","article-title":"Evaluation and treatment of amiodarone-induced thyroid disorders","volume":"106","author":"Ylli","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aed.2025.06.006_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/CCM.0000000000004078","article-title":"Thyroid storm in the ICU: a retrospective multicenter study","volume":"48","author":"Bourcier","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aed.2025.06.006_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"2018 European thyroid association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"7","author":"Bartalena","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.aed.2025.06.006_bib4","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical review: clinical utility of TSH receptor antibodies","volume":"98","author":"Barbesino","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aed.2025.06.006_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.eprac.2022.01.007","article-title":"Performance of thyroid-stimulating immunoglobulin bioassay and thyrotropin-binding inhibitory immunoglobulin assay for the diagnosis of Graves' disease in patients with active thyrotoxicosis","volume":"28","author":"Silva de Morais","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.aed.2025.06.006_bib6","first-page":"1463","article-title":"Identification of two different phenotypes of patients with amiodarone-induced thyrotoxicosis and positive thyrotropin receptor antibody tests","volume":"31","author":"Cappellani","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.aed.2025.06.006_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2024.113655","article-title":"Development and basic performance verification of a rapid homogeneous bioassay for agonistic antibodies against the thyroid-stimulating hormone receptor","volume":"528","author":"Hoshina","year":"2024","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.aed.2025.06.006_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2012.07.003","article-title":"TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis","volume":"12","author":"Tozzoli","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.aed.2025.06.006_bib9","first-page":"1087","article-title":"Fundamental evaluation of \u201cBIOSENSOR TSBAb YAMASA\u201d using cAMP biosensor and human thyroid stimulating hormone receptor co-expressing cells","volume":"79","author":"Tagami","year":"2022","journal-title":"Jpn J Med Pharm Sci"},{"key":"10.1016\/j.aed.2025.06.006_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1507\/endocrj.EJ19-0398","article-title":"Role of a new bioassay for thyroid-stimulating antibodies (aequorin TSAb) in Graves' ophthalmopathy","volume":"67","author":"Hiromatsu","year":"2020","journal-title":"Endocr J"},{"key":"10.1016\/j.aed.2025.06.006_bib11","doi-asserted-by":"crossref","first-page":"E1080","DOI":"10.1210\/jc.2011-2897","article-title":"A TSHR-LH\/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment","volume":"97","author":"Giuliani","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aed.2025.06.006_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3803\/EnM.2016.31.2.300","article-title":"Usefulness of measuring thyroid stimulating antibody at the time of antithyroid drug withdrawal for predicting relapse of Graves disease","volume":"31","author":"Kwon","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.aed.2025.06.006_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40618-023-02168-3","article-title":"Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis","volume":"47","author":"Cappellani","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.aed.2025.06.006_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-08-0348","article-title":"The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis","volume":"159","author":"Piga","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.aed.2025.06.006_bib15","first-page":"423","article-title":"Serum interleukin-6 in amiodarone-induced thyrotoxicosis","volume":"78","author":"Bartalena","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aed.2025.06.006_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amjcard.2025.02.002","article-title":"Exploring current diagnosis and management of amiodarone-induced thyrotoxicosis","volume":"242","author":"Oktaviono","year":"2025","journal-title":"Am J Cardiol"}],"container-title":["AACE Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:27:01Z","timestamp":1758626821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050915725000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S3050915725000529"],"URL":"https:\/\/doi.org\/10.1016\/j.aed.2025.06.006","relation":{},"ISSN":["3050-9157"],"issn-type":[{"type":"print","value":"3050-9157"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyrotropin (TSH)-Binding Inhibiting Immunoglobulin-Negative, Thyroid-Stimulating Antibody-Positive Amiodarone-Induced Thyrotoxicosis","name":"articletitle","label":"Article Title"},{"value":"AACE Endocrinology and Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aed.2025.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association of Clinical Endocrinologists. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}